We are seeking board-certified urologists and medical oncologists in the United States who manage patients with metastatic prostate cancer to take part in a short online survey about treatment decision-making.

Why Participate

• Contribute to research shaping the next generation of healthcare AI tools.
• Share your real-world clinical expertise in managing advanced prostate cancer.

• Format: Online survey.

Participants will be asked to:

• Complete a structured ~30-minute online survey.
• Share perspectives on how you evaluate and select systemic treatments for patients with prostate cancer.
• Submit all responses within the given timeline.

• Urologist or medical oncologist with an MD or DO.
• Board certified in your specialty.
• Hold an active, unrestricted US medical license and practice primarily in the United States.
• Spend at least 25% of your professional time in direct patient care.
• Have cared for prostate-cancer patients in the past 12 months, including at least one patient with metastatic hormone-sensitive (mHSPC) or castration-resistant (mCRPC) prostate cancer.
• Regularly manage metastatic prostate cancer, with primary or shared responsibility for selecting systemic treatment.

• Able to independently complete a ~30-minute online survey.

Work arrangement: Fully remote

Eligible countries: United States

Please note: this study is not open to anyone who has taken part in prostate-cancer market research in the past 3 months, or who (or whose immediate family) works for a pharmaceutical, diagnostics, market research, or advertising company, a wholesaler, or a specialty pharmacy.

• Compensation: One-time payment upon successful verification of the submission.